Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
KA ›
KADEPSI
Trademark search for:
KADEPSI
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-04-24 — Application filed
2019-04-27 — Application filed
2019-05-10 — Application filed
2019-07-04 — Assigned to examiner
2019-07-06 — Approved for pub - principal register
2019-07-24 — Notification of notice of publication e-mailed
2019-08-13 — Published for opposition
2019-08-13 — Official gazette publication confirmation e-mailed
2019-10-08 — Noa e-mailed - sou required from applicant
2020-02-07 — Sou teas extension received
2020-02-07 — Sou extension 1 filed
2020-02-07 — Sou extension 1 granted
2020-02-11 — Notice of approval of extension request e-mailed
2020-09-08 — Sou teas extension received
2020-09-08 — Sou extension 2 filed
2020-09-08 — Sou extension 2 granted
2020-09-10 — Notice of approval of extension request e-mailed
2021-02-23 — Sou teas extension received
2021-02-23 — Sou extension 3 filed
2021-02-23 — Sou extension 3 granted
2021-02-25 — Notice of approval of extension request e-mailed
2021-09-28 — Sou teas extension received
2021-09-28 — Sou extension 4 filed
2021-10-04 — Case assigned to intent to use paralegal
2021-10-08 — Sou extension 4 granted
2021-10-09 — Notice of approval of extension request e-mailed
2022-03-29 — Sou teas extension received
2022-03-29 — Sou extension 5 filed
2022-08-25 — Case assigned to intent to use paralegal
2022-08-25 — Sou extension 5 granted
2022-08-26 — Notice of approval of extension request e-mailed
2022-11-14 — Application abandoned
2022-11-14 — Application abandoned
2022-11-14 — Final status recorded
Owner Information
Glaxo Group Limited
Glaxo Group Limited
Correspondent
Merilee J. Arevalo GSK
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
